Skip to content

Hospital-Based Brain Health Screening for Older Adults

Hospital-Based Early Screening and Health Management of Cognitive Impairment and Alzheimer’s Disease in Older Adults Using Peripheral Blood Biomarkers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128927
Enrollment
Unknown
Registered
2026-07-28
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

late-onset Alzheimers disease, mild cognitive impairment, and other cognitive disorders

Interventions

Hospital-based older adult screening group:None

Sponsors

Hangzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Participants aged 60 years or older who undergo health examinations in the hospital. 2.Participants who voluntarily agree to participate and provide written informed consent. 3.Participants who are able to complete basic information collection and cognitive screening and who agree to the use of 1–3 mL of residual EDTA-anticoagulated blood remaining after routine complete blood count testing. 4.For participants with suspected cognitive decline who are unable to fully understand the informed consent information, written informed consent shall be provided by a legal guardian or legally authorized representative, while the participant’s own willingness and assent shall be respected whenever possible.

Exclusion criteria

Exclusion criteria: 1.Individuals who refuse to participate or refuse to provide informed consent. 2.Individuals who are unable to complete the screening due to severe physical illness, acute infection, severe mental disorder, or other conditions. 3.Participants without a residual blood sample from routine complete blood count testing that meets the quality requirements of the study. 4.Individuals considered unsuitable for participation by the investigators. 5.Participants who request withdrawal during the study.

Design outcomes

Primary

MeasureTime frame
Proportion of participants meeting assay-specific decision thresholds for AD-related peripheral blood biomarkers;

Secondary

MeasureTime frame
Abnormal rate of cognitive screening;

Countries

China

Contacts

Public ContactWang Ying

Hangzhou First People's Hospital

nancywangying@163.com+86 571 5600 7501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026